Cargando…
Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
BACKGROUND: Colorectal cancer (CRC) screening is the most efficient strategy to reduce disease-related mortality. Frequent aberrant DNA methylation is known to occur in selected genes and early during CRC development, which has emerged as a new epigenetic biomarker for early detection of CRC. Previo...
Autores principales: | Oh, Tae Jeong, Oh, Hyun Il, Seo, Yang Yei, Jeong, Dongjun, Kim, Changjin, Kang, Hyoun Woo, Han, Yoon Dae, Chung, Hyun Cheol, Kim, Nam Kyu, An, Sungwhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715626/ https://www.ncbi.nlm.nih.gov/pubmed/29225717 http://dx.doi.org/10.1186/s13148-017-0426-3 |
Ejemplares similares
-
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
por: Han, Yoon Dae, et al.
Publicado: (2019) -
Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial
por: Kim, Chang Woo, et al.
Publicado: (2021) -
Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
por: Song, Ji Hyeong, et al.
Publicado: (2023) -
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
por: Zhang, Weisong, et al.
Publicado: (2021) -
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Publicado: (2022)